台股 » 旭富 » 個股財報 » 每月營收

旭富

(4119)
可現股當沖
  • 股價
    94.0
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    262
  • 產業
    上市 生技醫療類股 ▼1.83%
  • 本地時間:13:35(已收盤)

    352人加入追蹤

    立即追蹤

旭富 (4119) 財務報表-每月營收
月營收報表

因應IFRSs國際會計準則,本報表在2013年以前為「個別營收」,2013年以後為「合併營收」。

旭富 (4119) 月營收分析比較圖

旭富 (4119) 月營收報表

年度/月份營業收入(單位:千元)累計營業收入(單位:千元)
單月營收去年同月營收單月月增率單月年增率累計營收去年累計營收累積年增率
2024/11155,513108,587-7.6%43.2%1,445,7881,115,42729.6%
2024/10168,38594,09727.2%78.9%1,290,2751,006,84028.1%
2024/09132,34094,102-12%40.6%1,121,889912,74322.9%
2024/08150,44298,81310.2%52.2%989,549818,64120.9%
2024/07136,51264,93418.4%110.2%839,107719,82816.6%
2024/06115,25856,2600%104.9%702,595654,8947.3%
2024/05115,296130,868-28.9%-11.9%587,338598,634-1.9%
2024/04162,162125,98713.4%28.7%472,041467,7660.9%
2024/03142,986143,35093.2%-0.3%309,879341,779-9.3%
2024/0274,003107,645-20.3%-31.3%166,893198,430-15.9%
2024/0192,89090,7844.7%2.3%92,89090,7842.3%
2023/1288,73288,585-18.3%0.2%1,204,159899,73833.8%
2023/11108,58760,77015.4%78.7%1,115,427811,15437.5%
2023/1094,09776,4110%23.1%1,006,840750,38434.2%
2023/0994,102130,095-4.8%-27.7%912,743673,97335.4%
2023/0898,813124,84552.2%-20.9%818,641543,87850.5%
2023/0764,93449,64915.4%30.8%719,828419,03371.8%
2023/0656,26060,923-57%-7.7%654,894369,38477.3%
2023/05130,86872,3963.9%80.8%598,634308,46194.1%
2023/04125,98748,043-12.1%162.2%467,766236,06698.2%
2023/03143,35097,64233.2%46.8%341,779188,02381.8%
2023/02107,64526,95918.6%299.3%198,43090,381119.5%
2023/0190,78463,4222.5%43.1%90,78463,42243.1%
2022/1288,58539,41245.8%124.8%899,738864,2174.1%
2022/1160,77048,764-20.5%24.6%811,154824,805-1.6%
2022/1076,41147,590-41.3%60.6%750,384776,042-3.3%
2022/09130,09569,9844.2%85.9%673,973728,452-7.5%
2022/08124,84565,351151.4%91%543,878658,468-17.4%
2022/0749,64992,919-18.5%-46.6%419,033593,117-29.4%
2022/0660,92362,243-15.8%-2.1%369,384500,198-26.1%
2022/0572,39667,77850.7%6.8%308,461437,955-29.6%
2022/0448,04346,551-50.8%3.2%236,066370,177-36.2%
2022/0397,64278,628262.2%24.2%188,023323,626-41.9%
2022/0226,959117,932-57.5%-77.1%90,381244,998-63.1%
2022/0163,422127,06660.9%-50.1%63,422127,066-50.1%
2021/1239,41278,498-19.2%-49.8%864,2172,689,222-67.9%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章